New hope for Parkinson's: drug pump studied for earlier use

NCT ID NCT06916507

Recruiting now Disease control Sponsor: AbbVie Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study looks at how well the drug combination Foslevodopa/Foscarbidopa works for people with early advanced Parkinson's disease in everyday German clinics. About 125 adults aged 18-64 who are already prescribed this drug will be followed for up to 12 months. Researchers will track changes in 'OFF' time (when symptoms return between doses), quality of life, and work ability.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

Foslevodopa/Foscarbidopa (a drug combination given as a continuous infusion under the skin)

What this could lead to

If successful, this study could show that starting this treatment earlier in advanced Parkinson's helps control motor symptoms and improves daily life and work ability.

What could go wrong

This is an observational study, not a controlled trial, so results may be less reliable. It is small (125 people) and only follows patients for 12 months, so long-term benefits or risks remain unclear.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Parkinson disease

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

PARKINSON'S DISEASE

Contacts and locations

Show contact details

Study contacts

Contact

Phone: •••-•••-•••• Email: •••••@•••••

Locations

Asklepios Fachklinikum Stadtroda /ID# 274162
RECRUITING

Stadtroda, Thuringia, 07646, Germany
Cellitinnen-NTC Neurologisches Therapiecentrum /ID# 277865
RECRUITING

Cologne, North Rhine-Westphalia, 50668, Germany
Klinikum Dortmund Klinikzentrum Mitte /ID# 280222
RECRUITING

Dortmund, North Rhine-Westphalia, 44137, Germany
Klinikum Ernst von Bergmann /ID# 274176
RECRUITING

Potsdam, Brandenburg, 14467, Germany
Klinikum Ingolstadt /ID# 280573
RECRUITING

Ingolstadt, Bavaria, 85049, Germany
Klinikum Lippe Detmold /ID# 279451
RECRUITING

Detmold, North Rhine-Westphalia, 32756, Germany
Klinikum der Universitaet Muenchen Grosshadern /ID# 274168
RECRUITING

Munich, Bavaria, 81337, Germany
Knappschaftskrankenhaus Bottrop /ID# 274284
RECRUITING

Bottrop, North Rhine-Westphalia, 46242, Germany
Krankenhaus Martha-Maria Halle-Dolau /ID# 274174
RECRUITING

Halle, Saxony-Anhalt, 06120, Germany
Parkinson-Klinik Ortenau GmbH&Co KG /ID# 274161
RECRUITING

Wolfach, Baden-Wurttemberg, 77709, Germany
Praxis MD Oehlwein /ID# 274222
RECRUITING

Gera, Thuringia, 07551, Germany
Praxis Prof. Kassubek/Prof. Riecker /ID# 274165
RECRUITING

Ulm, Baden-Wurttemberg, 89073, Germany
Universitaetskliniken Giessen und Marburg /ID# 274224
RECRUITING

Marburg, Hesse, 35043, Germany
Universitaetsklinikum Carl Gustav Carus Dresden /ID# 274167
RECRUITING

Dresden, Saxony, 01307, Germany
Universitaetsklinikum Erlangen /ID# 280831
RECRUITING

Erlangen, Bavaria, 91054, Germany
Universitaetsklinikum Heidelberg /ID# 274164
RECRUITING

Heidelberg, Baden-Wurttemberg, 69120, Germany
Universitaetsklinikum Tuebingen /ID# 275828
RECRUITING

Tübingen, Baden-Wurttemberg, 72076, Germany